AI-designed mRNA vaccine formulations hold up at 37 °C for more than 2 months
Solid-state mRNA vaccine formulations kept 100% of their bioactivity after more than 2 months at 37 °C, a study in Nature Biotechnology reports. Today's mRNA-lipid nanoparticle vaccines need ultra-cold storage. The team used an AI framework called AGENT, which reached the result in six iterations over 1 month. Tested in rodents and non-human primates, the dry doses drew immune responses non-inferior to freshly prepared soluble vaccines.
Ultra-cold storage limits how far mRNA vaccines can be distributed, and formulations that survive 37 °C go after that constraint directly.
Source: Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI - Nature Biotechnology (nature.com).
Written by the HappyGood desk from the primary source linked above and checked against it. Every story links its source. Corrections: [email protected].
More from the archive
- Bringing back the American chestnut: four approaches to a forest giant's return October 14, 2026
- 5 search and rescue teams, RCMP find stranded person in canyon above Penticton October 14, 2026
- Mackenzie Macdonald, 16, heads to the Youth Olympics for Australia in taekwondo October 13, 2026
- Parksville festival volunteers help deliver record $89,270 donation October 12, 2026
- Police fetch antivenom as three Blue Mountains rescues unfold in a day October 12, 2026